The Bernal Institute hosts a multidisciplinary team of world-leading materials scientists and engineers at UL. Bernal represents a €100m+ investment in world-class characterisation, modelling and manufacturing facilities concentrated in 20,000 m of high quality research space.
Bernal research focuses on the synthesis (making), characterisation (measuring) and design (inventing) of nano, meso and macro structured materials.
Our Vision is to become the leading international research institute for the scientific design and manufacture of structured materials to meet global challenges, particularly in the areas of health, energy and the environment.
Our Mission is to develop disruptive technologies related to Health, Energy and Environment that will create a legacy of scientific achievement in structured materials research that benefits future generations.
Bernal’s four research clusters are:
- Molecular & Nano Materials (MOL)
- Bio Materials (BIO)
- Composite Materials (Composites)
- Process Engineering (PROC)
The clusters are supported centrally by an operations support unit and by a team of instrument scientist staff dedicated to maintaining state-of-the-art equipment that is essential to the needs of the clusters’ scientists and engineers.
Research News
Events
Bernal Podcasts
Understanding infertility
Newstalk radio presenter Jonathan McCrea, talks to Reproductive Biology expert Dr Sean Fair about infertility; why poor sperm quality is a factor and a new technology to help IVF.
Futureproof Extra:
Prof. Damien Thompson discuses a new Molecule that will be used for next-generation computers modelled on the human brain.
Cracking the code for continuous processing and personalised medicine.
Bernal Chair in Pharmaceutical Powder Engineering Gavin Walker describes medicines of the future that will radically improve patients quality of life
PhD researcher Oisín Kavanagh discusses multi drug formulations
Oisín Kavanagh discusses advances in the distribution and production of medicines which could help to alleviate the financial burden on the State while in turn easing the burden on patients, making drug delivery easier and more effective.
To read the latest advice for the UL community on Covid19 – click here
